198 Costimulatory antigen receptor (CoStAR): a novel platform that enhances the activity of tumor infiltrating lymphocytes (TILs)

• Sujita Sukumaran,
• Gray Kueberuwa,
• Eric Gschweng,
• Milena Kalaitsidou,
• Michelle Mojadidi,
• Clare Yarka,
• Yong (Stella) Ouyang,
• John Bridgeman,
• Bob Hawkins,
• Rubén Alvarez-Rodríguez

Affiliations

Sujita Sukumaran

Aff1 0000 0001 2160 926Xgrid.39382.33Center for Cell and Gene TherapyBaylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital 77030 Houston TX USA

Gray Kueberuwa

Aff1 0000000121662407grid.5379.8Clinical and Experimental Immunotherapy Group, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Division of Cancer SciencesThe University of Manchester Wilmslow Road, Withington M20 4QL Manchester UK

Eric Gschweng

4University of California, Los Angeles, USA

Milena Kalaitsidou

Instil Bio, Inc., Dallas, TX, USA

Michelle Mojadidi

Instil Bio, Inc., Dallas, TX, USA

Clare Yarka

Instil Bio, Inc., Dallas, TX, USA

Yong (Stella) Ouyang

Instil Bio, Inc., Dallas, TX, USA

John Bridgeman

Instil Bio, Inc., Dallas, TX, USA

Bob Hawkins

Instil Bio, Inc., Dallas, TX, USA

Rubén Alvarez-Rodríguez

Instil Bio, Inc., Dallas, TX, USA